Bernd Disse

7.9k total citations · 1 hit paper
37 papers, 2.3k citations indexed

About

Bernd Disse is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Bernd Disse has authored 37 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 22 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Bernd Disse's work include Asthma and respiratory diseases (20 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Inhalation and Respiratory Drug Delivery (12 papers). Bernd Disse is often cited by papers focused on Asthma and respiratory diseases (20 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (18 papers) and Inhalation and Respiratory Drug Delivery (12 papers). Bernd Disse collaborates with scholars based in Germany, United Kingdom and Netherlands. Bernd Disse's co-authors include Ronald Dahl, Peter M.A. Calverley, J.A. van Noord, Rudolf Hammer, G. Speck, K. L. Rominger, Helen Finnigan, H Magnussen, Kay Tetzlaff and Henrik Watz and has published in prestigious journals such as New England Journal of Medicine, Pharmacological Reviews and CHEST Journal.

In The Last Decade

Bernd Disse

37 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD

2014 406 citations H Magnussen, Bernd Disse et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernd Disse Germany	19	2.1k	1.7k	145	101	71	37	2.3k
Donald Banerji United States	29	3.8k 1.8×	3.2k 1.8×	49 0.3×	119 1.2×	68 1.0×	155	4.0k
Glenn Crater United States	24	1.4k 0.7×	1.1k 0.7×	76 0.5×	16 0.2×	22 0.3×	80	1.7k
Hitesh Pandya United Kingdom	20	440 0.2×	234 0.1×	140 1.0×	34 0.3×	95 1.3×	64	1.1k
Sally Lettis United Kingdom	17	1.4k 0.7×	1.2k 0.7×	215 1.5×	140 1.4×	14 0.2×	41	1.9k
Matthew Ball United States	7	270 0.1×	344 0.2×	60 0.4×	15 0.1×	9 0.1×	11	736
Bernardino Barceló Martín Spain	12	227 0.1×	202 0.1×	67 0.5×	81 0.8×	20 0.3×	66	787
Chou‐Chin Lan Taiwan	16	413 0.2×	166 0.1×	136 0.9×	11 0.1×	57 0.8×	90	828
E. McClean United Kingdom	15	312 0.1×	336 0.2×	65 0.4×	16 0.2×	4 0.1×	32	943
Frank M. MacDonald United States	10	324 0.2×	215 0.1×	74 0.5×	6 0.1×	14 0.2×	21	820
Xueqing Yu China	15	337 0.2×	73 0.0×	128 0.9×	99 1.0×	5 0.1×	69	747

Countries citing papers authored by Bernd Disse

Since Specialization

Citations

This map shows the geographic impact of Bernd Disse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Disse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Disse more than expected).

Fields of papers citing papers by Bernd Disse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernd Disse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Disse. The network helps show where Bernd Disse may publish in the future.

Co-authorship network of co-authors of Bernd Disse

This figure shows the co-authorship network connecting the top 25 collaborators of Bernd Disse. A scholar is included among the top collaborators of Bernd Disse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernd Disse. Bernd Disse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anderson, Sandra D., Paul J. Atkins, Per Bäckman, et al.. (2022). Inhaled Medicines: Past, Present, and Future. Pharmacological Reviews. 74(1). 48–118. 79 indexed citations

Singh, Dave, Naimat Ullah Khan, James Dean, et al.. (2019). FEV1 recovery following methacholine challenge in asthma: Variability and comparison of methods. Pulmonary Pharmacology & Therapeutics. 60. 101876–101876. 1 indexed citations

Rodríguez-Roisin, Roberto, Kay Tetzlaff, Henrik Watz, et al.. (2016). Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease. International Journal of COPD. Volume 11. 1973–1981. 18 indexed citations

Watz, Henrik, Kay Tetzlaff, Emiel F.�M. Wouters, et al.. (2016). Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial. The Lancet Respiratory Medicine. 4(5). 390–398. 291 indexed citations

Calverley, Peter M.A., Kay Tetzlaff, Claus Vogelmeier, et al.. (2016). LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD. OA1973–OA1973. 1 indexed citations

Calverley, Peter, Pascal Chanez, Ronald Dahl, et al.. (2015). The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study. Pneumologie. 69(S 01). 1 indexed citations

Magnussen, H, Bernd Disse, Roberto Rodríguez-Roisin, et al.. (2014). Exacerbation Risk Is Not Worse When ICS Are Withdrawn in a Stepwise Manner in Severe to Very Severe COPD Patients Receiving LAMA+LABA: The WISDOM Study. CHEST Journal. 146(4). 63A–63A. 2 indexed citations

Magnussen, H, Henrik Watz, Anne Kirsten, et al.. (2014). Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale. Respiratory Medicine. 108(4). 593–599. 30 indexed citations

Anzueto, Antonio, et al.. (2014). Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol. International Journal of COPD. 9. 813–813. 15 indexed citations

10.

Magnussen, H, Bernd Disse, Roberto Rodríguez-Roisin, et al.. (2014). Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD. New England Journal of Medicine. 371(14). 1285–1294. 406 indexed citations breakdown →

11.

Magnussen, H, Bernd Disse, Roberto Rodríguez-Roisin, et al.. (2014). The Impact of Stepwise Withdrawal of ICS on FEV1, mMRC, and SQRQ in Severe to Very Severe COPD Patients Treated With LAMA+LABA: The WISDOM Study. CHEST Journal. 146(4). 76A–76A. 2 indexed citations

12.

Sharma, Ashish, Jens M. Hohlfeld, Piet J.G. Cornelissen, et al.. (2013). Comparison of the pharmacokinetics and pharmacodynamics of once daily tiotropium Respimat® and tiotropium HandiHaler® in COPD patients. European Respiratory Journal. 42(Suppl 57). 4631–4631. 2 indexed citations

13.

Wise, Robert A., Antonio Anzueto, Otto W. Witte, et al.. (2013). Tiotropium Respimat Inhaler and the Risk of Death in COPD. New England Journal of Medicine. 369(16). 1491–1501. 256 indexed citations

14.

Wise, Robert A., Antonio Anzueto, Peter M.A. Calverley, et al.. (2013). The Tiotropium Safety and Performance in Respimat® Trial (TIOSPIR®), a large scale, randomized, controlled, parallel-group trial-design and rationale. Respiratory Research. 14(1). 40–40. 42 indexed citations

15.

Hall, Ian P., Maria Sarno, Bernd Disse, et al.. (2012). Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid. 40. 1792. 6 indexed citations

16.

Kerstjens, Huib A.M., Bernd Disse, Theo A. Bantje, et al.. (2011). Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial. Journal of Allergy and Clinical Immunology. 128(2). 308–314. 211 indexed citations

17.

Noord, J.A. van, J. Aumann, Wim Janssens, et al.. (2005). Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD. European Respiratory Journal. 26(2). 214–222. 255 indexed citations

18.

Disse, Bernd. (2001). Antimuscarinic treatment for lung diseases. Life Sciences. 68(22-23). 2557–2564. 30 indexed citations

19.

Disse, Bernd, G. Speck, K. L. Rominger, Theodore J. Witek, & Rudolf Hammer. (1999). Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung disease. Life Sciences. 64(6-7). 457–464. 213 indexed citations

20.

Disse, Bernd, et al.. (1993). Ba 679 BR, A novel long-acting anticholinergic bronchodilator. Life Sciences. 52(5-6). 537–544. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact